Treatment Recommendations Based on Gleason Score With a Life Expectancy of > 10-15 Years With the Diagnosis of Intermediate-Risk PCa, a PSA Level of < 20 ng/mL, and Disease Confined to the Prostate. Here, KLK3 is linked to posterior cortical atrophy.